King's College London

Research portal

Is the pharmaceutcal industry overpowering the medical profession?

Research output: Contribution to journalArticle

Nazia Din, Maria Kordowicz

Original languageEnglish
Pages (from-to)9-18
JournalThe British Student Doctor
Issue number2
Early online date30 Jun 2019
Publication statusPublished - Jun 2019


King's Authors


Doctors’ reported loss of autonomy in the current policy climate and the
subsequent deprofessionalisation of medicine can be attributed to many factors. The pharmaceutical industry accounts for a large proportion of healthcare costs, with the professional relationship between the industry and medical profession raising ethical concerns. Developing potentially life-saving products and potentiating scientific advances are some of the many good attributes of the pharmaceutical industry. The dependence of medical care on the production of pharmaceuticals is undeniable. However, it could be argued that the pharmaceutical industry takes advantage of this relationship, fuelled by financial motive. Conversely, there could be a complex interplay of factors driving a power imbalance in the pharma/clinical relationship. By reviewing literature in the feld, this viewpoint article explores these multifaceted factors.

Download statistics

No data available

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454